Patent · US Active

Methods and compositions for the treatment of gastrointestinal disorders

US7704947B2 · kind B2 · utility

16Cited by
7References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2007
Grant dateApr 27, 2010
Priority date
Expiry dateDec 21, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), Crohn's disease, ulcerative colitis, Inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation, and constipation associated with neuropathic disorders as well as other conditions and disorders using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.